Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| platelet | 8 studies | 29% ± 12% | |
| megakaryocyte | 5 studies | 67% ± 23% |
Insufficient scRNA-seq data for expression of GP1BA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 97% | 61.27 | 86 / 89 | 69% | 1.73 | 622 / 901 |
| esophagus | 95% | 58.79 | 1366 / 1445 | 71% | 2.29 | 130 / 183 |
| lung | 99% | 207.59 | 572 / 578 | 58% | 1.50 | 668 / 1155 |
| skin | 98% | 214.65 | 1780 / 1809 | 55% | 4.03 | 261 / 472 |
| thymus | 96% | 69.03 | 626 / 653 | 53% | 1.62 | 320 / 605 |
| brain | 80% | 47.00 | 2124 / 2642 | 62% | 1.12 | 435 / 705 |
| intestine | 97% | 113.29 | 940 / 966 | 41% | 1.11 | 216 / 527 |
| breast | 85% | 58.07 | 390 / 459 | 49% | 1.40 | 543 / 1118 |
| prostate | 96% | 61.18 | 234 / 245 | 37% | 0.60 | 187 / 502 |
| stomach | 80% | 41.50 | 286 / 359 | 52% | 1.27 | 150 / 286 |
| ovary | 88% | 50.19 | 159 / 180 | 37% | 0.71 | 159 / 430 |
| liver | 96% | 62.68 | 217 / 226 | 24% | 0.83 | 98 / 406 |
| uterus | 94% | 56.22 | 159 / 170 | 21% | 0.46 | 96 / 459 |
| bladder | 86% | 53.62 | 18 / 21 | 26% | 0.64 | 132 / 504 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 26.39 | 29 / 29 |
| spleen | 100% | 248.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 244.26 | 921 / 929 | 0% | 0 | 0 / 0 |
| pancreas | 49% | 17.44 | 161 / 328 | 43% | 1.71 | 76 / 178 |
| adipose | 85% | 47.77 | 1026 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 85% | 46.67 | 1135 / 1335 | 0% | 0 | 0 / 0 |
| heart | 81% | 38.05 | 699 / 861 | 0% | 0 | 0 / 0 |
| muscle | 81% | 49.21 | 650 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 30% | 9.18 | 77 / 258 | 27% | 0.46 | 63 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 56% | 3.22 | 25 / 45 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.12 | 6 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007155 | Biological process | cell adhesion |
| GO_0070493 | Biological process | thrombin-activated receptor signaling pathway |
| GO_0007596 | Biological process | blood coagulation |
| GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
| GO_0042730 | Biological process | fibrinolysis |
| GO_0035855 | Biological process | megakaryocyte development |
| GO_0030168 | Biological process | platelet activation |
| GO_1903238 | Biological process | positive regulation of leukocyte tethering or rolling |
| GO_0030193 | Biological process | regulation of blood coagulation |
| GO_0007597 | Biological process | blood coagulation, intrinsic pathway |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0010572 | Biological process | positive regulation of platelet activation |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_1990779 | Cellular component | glycoprotein Ib-IX-V complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0009986 | Cellular component | cell surface |
| GO_0015057 | Molecular function | thrombin-activated receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GP1BA |
| Protein name | Platelet glycoprotein Ib alpha polypeptide type 3 Platelet glycoprotein Ib alpha chain (GP-Ib alpha) (GPIb-alpha) (GPIbA) (Glycoprotein Ibalpha) (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin] Mutant platelet membrane glycoprotein Ib-alpha Platelet glycoprotein Ib alpha polypeptide type 2 Glycoprotein Ib alpha polypeptide T624 deletion mutant Platelet glycoprotein Ib alpha Platelet membrane glycoprotein Ib-alpha Glycoprotein Ib alpha polypeptide A1562T1563 deletion mutant Glycoprotein Ib alpha polypeptide G942 deletion mutant Platelet glycoprotein Ib alpha polypeptide type 4 |
| Synonyms | |
| Description | FUNCTION: GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium. |
| Accessions | E0D851 A0A193AUC0 E0D852 L7UV37 E0D853 A0A193AU54 L7URT5 A0A193AUV8 A5CKE2 ENST00000329125.6 E0D854 A0A193AUJ5 L7UYB8 P07359 |